Idera Pharmaceuticals, Inc.
http://www.iderapharma.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Idera Pharmaceuticals, Inc.
Russia-Ukraine War Likely To Claim Sputnik V Partners As Casualty
In light of the Russia-Ukraine conflict, Scrip looks at data to gauge if manufacturing partners for COVID-19 vaccine Sputnik V or Light, in India, China and Korea could be left holding unsold inventory earmarked for exports
Neuraxpharm Expands In Switzerland With New Local Head
Neuraxpharm has appointed Jörg Gärtner to lead its business in Switzerland, as the CNS specialist prepares to roll out its medical cannabis portfolio in the region.
Eargo To Pay $34M+ To Resolve False-Claims Allegations
The company, which denies the allegations, allegedly sold hearing aids to federal employees and billed a government insurance plan without the required hearing assessment.
CDR-Life Raises $76m To Develop Next-Generation T-Cell Engagers
The Swiss biotech has raised an impressive series A round which will go towards the development of T-cell engagers based on its unique technology, with an eye to reducing off-tumor activity.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
-
Biotechnology
- Antisense, Oligonucleotides
- Large Molecule
- Other Names / Subsidiaries
-
- Hybridon Inc.